Skip to main content
Genes & Development logoLink to Genes & Development
. 2019 Jun 1;33(11-12):669–683. doi: 10.1101/gad.322024.118

The histone chaperone CAF-1 cooperates with the DNA methyltransferases to maintain Cd4 silencing in cytotoxic T cells

Charles Ng 1, Martin Aichinger 2, Tung Nguyen 1,6, Christy Au 1,6, Tariq Najar 1, Lin Wu 1, Kai R Mesa 1, Will Liao 3, Jean-Pierre Quivy 4, Benjamin Hubert 3, Genevieve Almouzni 4, Johannes Zuber 2, Dan R Littman 1,5
PMCID: PMC6546056  PMID: 30975723

In this study, Ng et al. investigated the maintenance of silent gene states and how the Cd4 gene is stably repressed in CD8+ T cells. Using CRISPR and shRNA screening, they identified the histone chaperone CAF-1 as a critical component for Cd4 repression and propose that the heritable silencing of the Cd4 gene in CD8+ T cells exploits cooperative functions among the DNA methyltransferases, CAF-1, and histone-modifying enzymes.

Keywords: CAF-1, CD4, cytotoxic T cell, DNA methylation, DNMT, epigenetics, gene silencing, histone chaperone, lineage commitment, T-cell development

Abstract

The transcriptional repression of alternative lineage genes is critical for cell fate commitment. Mechanisms by which locus-specific gene silencing is initiated and heritably maintained during cell division are not clearly understood. To study the maintenance of silent gene states, we investigated how the Cd4 gene is stably repressed in CD8+ T cells. Through CRISPR and shRNA screening, we identified the histone chaperone CAF-1 as a critical component for Cd4 repression. We found that the large subunit of CAF-1, Chaf1a, requires the N-terminal KER domain to associate with the histone deacetylases HDAC1/2 and the histone demethylase LSD1, enzymes that also participate in Cd4 silencing. When CAF-1 was lacking, Cd4 derepression was markedly enhanced in the absence of the de novo DNA methyltransferase Dnmt3a but not the maintenance DNA methyltransferase Dnmt1. In contrast to Dnmt1, Dnmt3a deficiency did not significantly alter levels of DNA methylation at the Cd4 locus. Instead, Dnmt3a deficiency sensitized CD8+ T cells to Cd4 derepression mediated by compromised functions of histone-modifying factors, including the enzymes associated with CAF-1. Thus, we propose that the heritable silencing of the Cd4 gene in CD8+ T cells exploits cooperative functions among the DNA methyltransferases, CAF-1, and histone-modifying enzymes.


The establishment of distinct gene expression programs in given lineages and their maintenance through subsequent cell divisions are important features of animal development. These properties are readily observed in hematopoiesis, during which stem cells give rise to numerous cell lineages of diverse functions. Among cells of the adaptive immune system, the development of the major subsets of T cells—the CD4+ helper or regulatory T cells and the CD8+ cytotoxic T cells—provides an example of a binary decision followed by maintenance of cell lineage properties. Expression of the coreceptors CD4 and CD8 is coupled to the unique transcriptional programs of these functionally distinct lineages. In addition, CD4 and CD8 expression mark distinct stages of maturation in the thymus, and investigation of their transcriptional regulation has been widely used to understand lineage commitment and cellular memory (Taniuchi 2016). Early thymic precursors are double-negative (DN) for both CD4 and CD8, and, following selection for productive rearrangements of the Tcrb locus (β selection), there is up-regulation of both CD4 and CD8 (double-positive [DP] stage). During the DP stage, T cells rearrange the genes encoding TCRα, and those cells with heterodimeric TCRs that interact with self-peptide bound to MHC class II and class I undergo selection and differentiate into either CD4 single-positive (CD4SP) or CD8 single-positive (CD8SP) cells, respectively, that subsequently exit the thymus as mature helper/regulatory and cytotoxic T cells.

CD4 expression during development is achieved by the coordinated activity of multiple enhancers and a silencer at the Cd4 locus (for review, see Issuree et al. 2017). The Cd4 silencer (S4) resides in the first intron of the Cd4 gene, and its activity is mediated by direct binding of Runx1 and Runx3 transcription factors (Sawada et al. 1994; Taniuchi et al. 2002; Setoguchi et al. 2008). Deletion of S4 or Runx complexes during T-cell development leads to Cd4 derepression in DN thymocytes and a failure to establish silencing in CD8SP cells (Zou et al. 2001; Setoguchi et al. 2008). In contrast, deletion of S4 or deficiency of Runx factors in mature CD8+ T cells does not result in up-regulation of CD4, consistent with earlier establishment of heritable epigenetic marks that silence the locus (Zou et al. 2001; Shan et al. 2017). Thus, S4 mediates the establishment of silencing during T-cell development but is later dispensable for its maintenance in CD8+ T cells. Recently, some of the molecular processes responsible for maintaining Cd4 repression in proliferating CD8+ T cells were described as involving DNA methylation and covalent histone modifications (Sellars et al. 2015; Verbaro et al. 2018). In mammals, DNA methylation occurs at cytosines predominantly in the context of the CpG dinucleotide and is generally associated with transcriptional repression, although the extent of its instructive role in gene silencing remains an area of investigation (Bestor et al. 2015; Schübeler 2015). The DNA methyltransferase (DNMT) enzymes critical in establishing methylation patterns during embryogenesis and gametogenesis are Dnmt3a, Dnmt3b, and Dnmt3c and are often referred to as the de novo DNA methyltransferases. In contrast, Dnmt1 has been ascribed the predominant role in maintaining methylation after DNA replication and is referred to as the maintenance DNA methyltransferase (Li and Zhang 2014; Barau et al. 2016). Dnmt1 is recruited to the replication fork through interactions with PCNA, the sliding clamp, and Uhrf1, which binds to hemimethylated DNA (Smith and Meissner 2013).

In eukaryotes, genomic DNA is organized into chromatin, in which the basic subunit is the nucleosome. The nucleosome is composed of ∼147 bp of dsDNA wrapped around a histone octamer core particle comprised of one tetramer of H3–H4 flanked by two dimers of H2A–H2B, and these core particles are connected through linker DNA. Posttranslational modifications (PTMs) of nucleosomal histones provide marks that can regulate gene expression (Bannister and Kouzarides 2011). Examples include H3/H4 acetylation and H3K4 methylation, which are generally associated with activated or permissive transcription states, and H3K9 and H3K27 methylation, which are generally associated with gene silencing (Jenuwein and Allis 2001). These dynamic changes have been involved in regulating cell fate decision and maintenance of cell identity (Yadav et al. 2018). Deficiencies in the DNA methyltransferases or the histone methyltransferase G9a, which catalyzes H3K9 monomethylation and dimethylation (H3K9me1/2), can cause Cd4 derepression in CD8+ T cells during cell proliferation (Sellars et al. 2015; Verbaro et al. 2018). Furthermore, DNA methylation is regulated during T-cell development. CD4SP cells undergo demethylation at the Cd4 locus, relative to DP and CD8SP cells, in a differentially methylated region (DMR) spanning +3.2 to −0.7 kb relative to the Cd4 transcriptional start site (TSS) (Sellars et al. 2015). Interestingly, DP thymocytes harbor active histone modifications at the Cd4 locus despite having hypermethylated DNA. This configuration suggests cross-talk and hierarchical interactions between these regulatory pathways (Yu et al. 2008; Chong et al. 2010; Sellars et al. 2015). Thus, the study of the Cd4 locus represents an attractive system to understand how DNA methylation and other epigenetic modifications may cooperate to regulate transcriptional memory, an integral component of vertebrate development (Cedar and Bergman 2009).

In this study, we sought to identify additional factors involved in the maintenance of Cd4 silencing and asked how they cooperate with the DNA methylation machinery to confer heritability of the repressed state. Through CRISPR and shRNA screening, we identified the histone chaperone complex CAF-1 as another factor required for Cd4 silencing. CAF-1 is a conserved heterotrimeric complex comprised of Chaf1a, Chaf1b, and Rbbp4 that promotes H3–H4 deposition during DNA replication in S phase (Smith and Stillman 1989; Kaufman et al. 1995). The CAF-1 complex has well-established roles in the maintenance of heterochromatin and cell identity, but its function in regulating gene expression in primary somatic cells and its coordination with DNA methylation in gene silencing have been largely unexplored (Tchenio et al. 2001; Krawitz et al. 2002; Houlard et al. 2006; Dohke et al. 2008; Quivy et al. 2008; Huang et al. 2010; Heyd et al. 2011; Cheloufi et al. 2015; Ishiuchi et al. 2015; Roelens et al. 2017). Mechanistically, we found that the CAF-1 subunit Chaf1a associates with the histone deacetylases (HDACs) HDAC1/2 and the histone demethylase LSD1, enzymes that counteract histone marks associated with active transcription. CAF-1 deficiency also induced accumulation of “active” histone marks at the Cd4 locus in CD8+ T cells. In assessing concomitant Dnmt1 and CAF-1 deficiency, we found that CD8+ T cells exhibited a modest increase in Cd4 derepression with hypomethylation of the Cd4 locus. Remarkably, CAF-1 combined with Dnmt3a deficiency did not cause significant demethylation of the Cd4 locus but markedly increased Cd4 derepression. Furthermore, loss of Dnmt3a led to Cd4 derepression that was significantly enhanced by pharmacological inhibition of HDACs or deficiency of CAF-1-associated histone-modifying enzymes. Thus, CAF-1 and the DNA methyltransferases cooperate to maintain Cd4 silencing and thereby contribute to CD8+ T-cell function and lineage integrity.

Results

The histone chaperone CAF-1 is required for the maintenance of Cd4 repression in CD8+ T cells

We used CD8+ T cells to screen for factors involved in the maintenance of Cd4 silencing. We targeted 648 genes associated with chromatin with a retroviral shRNA library consisting of 5048 shRNA clones. Transduced cells in the CD8+CD4+ and CD8+CD4 fractions were sorted, and shRNA clones enriched in the former set of cells were identified by DNA sequencing (Supplemental Fig. S1A,B). Retroviral shRNA clones corresponding to subunits of the histone chaperone complex CAF-1 (Supplemental Fig. S1C, blue) and Dnmt1 (Supplemental Fig. S1C, orange) were identified in the screen and found to up-regulate CD4 expression to varying degrees in validation experiments (Supplemental Fig. S1C). To further validate these identified chromatin regulators, we performed in parallel a candidate-based Cd4 derepression screen with retroviral sgRNA transduction of CD8+ T cells from Cas9Tg mice (Fig. 1A; Supplemental Table 1). Multiple guide RNAs (gRNAs) for CAF-1 subunits (Fig. 1A, blue) and the maintenance DNA methylation machinery (Fig. 1A, orange) induced CD4 up-regulation relative to negative control guides targeting genes lowly expressed in CD8+ T cells, the olfactory receptor Olfr2, and the CD4+ lineage transcription factor Thpok (Fig. 1A, black). We validated these initial findings by repeating the sgRNA targeting of all three CAF-1 subunits (Chaf1a, Chaf1b, and Rbbp4) (Fig. 1B, blue), which reproducibly up-regulated CD4 expression similarly to the previously reported mediator of Cd4 silencing, Dnmt1 (Fig. 1B, orange; Sellars et al. 2015). Although CAF-1 has a well-established role in the proliferation and viability of mammalian cells, the limited time frame of the sgRNA cultures and CAF-1 protein half-life were likely mitigating factors allowing us to target these essential genes.

Figure 1.

Figure 1.

CRISPR screening identifies histone chaperone CAF-1 as regulator of Cd4 silencing in mature CD8+ T cells. (A) One-hundred-eighty-two retroviral sgRNA constructs targeting 141 genes were transduced into Cas9Tg CD8+ T cells to screen for Cd4 derepression. Negative controls (Olfr2 and Thpok) are shown in black, CAF-1 subunits are shown in blue, and maintenance DNA methyltransferase components (Dnmt1 and Uhrf1) are shown in orange. (B) Validation of candidate genes from A by sgRNA transduction of Cas9Tg CD8+ T cells. Data are means ± SD. n = 4. (**) P < 0.01; (***) P < 0.001 by Student's t-test. (C) CD8+ T cells from wild-type (WT) or Dnmt1Chip/+ mice were isolated and transduced with the indicated shRNAs. Data are means ± SD. n = 5. (*) P < 0.05; (**) P < 0.01; (***) P < 0.001 by Student's t-test. (D) Dnmt3a-deficient or Dnmt3a-sufficient Cas9Tg CD8+ T cells were transduced with the indicated sgRNAs targeting CAF-1. Data are means ± SD. n = 4. (**) P < 0.01; (***) P < 0.001 by Student's t-test.

To begin dissecting potential interactions of CAF-1 and the DNA methyltransferases in Cd4 silencing, we next assayed the effects of combined targeting of both sets of factors. CAF-1 knockdown (KD) resulted in enhanced Cd4 derepression in CD8+ T cells from mice hypomorphic for Dnmt1 (Dnmt1chip/+) (Tucker et al. 1996) compared with wild-type (WT) mice (Fig. 1C). When cells were concomitantly deficient in CAF-1 and the de novo DNA methyltransferases (Cd4-Cre; Dnmt3af/f Dnmt3bf/f, referred to here as 3A3B knockout [KO]), we found a markedly enhanced effect, with the majority of repression due to Dnmt3a (Supplemental Fig. S1D). We further confirmed the critical role of Dnmt3a by targeting the CAF-1 subunits with sgRNAs transduced into Cas9Tg CD8+ T cells deficient for Dnmt3a (Cd4-Cre; Dnmt3af/f, referred to here as 3A KO), observing an enhancement similar to that seen with the shRNA KD (Fig. 1D). Thus, both CAF-1 and the DNA methyltransferases are essential for the maintenance of Cd4 silencing in cytotoxic T cells.

Dnmt3a deficiency enhances the repressive effects mediated by other replication fork-associated factors

From our candidate-based sgRNA screening, we also identified several other factors involved in Cd4 silencing—notably, the chromatin remodeling enzyme Smarca5 and the replicative helicase component Mcm2. Both factors have been found to be associated with replication foci, and Mcm2 has been implicated recently to have an additional role as a H3–H4 histone chaperone (Poot et al. 2004; Huang et al. 2015). We validated their functions by gene targeting using CRISPR and observed marked enhancement with Dnmt3a deficiency (Supplemental Fig. S2A,B). These data suggest that replication fork-associated factors in addition to CAF-1 also participate in Cd4 silencing and cooperate with Dnmt3a to bolster repressive function.

Dnmt3a represses Cd4 in mature CD8+ T cells, and its absence sensitizes to HDAC inhibitor-mediated derepression

Because we observed significantly greater Cd4 derepression by combining deficiencies of CAF-1 and Dnmt3a, we further explored their relationship in gene silencing. Previously, we reported that several CpGs acquire methylation during the differentiation of DP thymocytes into CD8SP cells in the thymus (Sellars et al. 2015). This raised the possibility that thymic deficiency of Dnmt3a (achieved by Dnmt3a deletion with Cd4-Cre) might lead to latent defects in silencing that manifest during T-cell activation. Thus, we decided to test Dnmt3a for a postthymic maintenance role in Cd4 repression by targeting the Dnmt3a and control Dnmt1 genes with electroporated sgRNA amplicons in naïve nonproliferating CD8+ T cells from Cas9Tg mice (Supplemental Fig. S3A). The electroporated cells were then activated and transduced with retroviral sgRNA targeting Chaf1a. Targeting Dnmt3a resulted in substantial Cd4 derepression as compared with targeting Dnmt1 (Supplemental Fig. S3A). We further tested for a postthymic role for Dnmt3a by ectopically expressing it in 3A KO CD8+ T cells and found that it could rescue Cd4 repression after Chaf1a KD (Fig. 2A). This depended on an intact DNA methyltransferase domain, as the catalytic-dead Dnmt3a_V712G mutant was unable to rescue silencing (Zhang et al. 2018). These results indicate that Dnmt3a is required for silencing in mature proliferating CD8+ T cells.

Figure 2.

Figure 2.

Dnmt3a deficiency in mature CD8+ T cells potentiates Cd4 derepression mediated by CAF-1 deficiency and activating histone modifications. (A) 3A KO CD8+ T cells were cotransduced with retroviral shRNA targeting Chaf1a together with retroviral overexpression vectors encoding WT or mutant Dnmt3A. Data are means ± SD. n = 3. (ns) Not statistically significant; (**) P < 0.01 by Student's t-test. (B) T cells from Cas9Tg mice were electroporated with the indicated amplicons (e_sgRNA) and subsequently sorted according to CD4 expression. Genomic DNA was isolated for bisulfite PCR sequencing of the +1600 region within the DMR. The schematic shows the relative density of CpG dinucleotides assessed (open circles), and arrowheads indicate the +1600 region and regulatory elements S4 and E4M. (C) WT or 3A KO CD8+ T cells were treated with increasing doses of pan-HDAC inhibitor trichostatin A (TSA). Data are means ± SD. n = 4. (**) P < 0.01; (***) P < 0.001 by Student's t-test. (D) Dnmt1Chip/+ or WT CD8+ T cells were treated with the HDAC inhibitor TSA and assayed for CD4 up-regulation. Data are means ± SD. n ≥ 4. (ns) Not statistically significant by Student's t-test.

Evidence for a repressive role of Dnmt3a in mature CD8+ T cells led us to speculate that it might also participate in DNA methylation maintenance with Dnmt1, as has been suggested in postmitotic neurons and other contexts (Feng et al. 2010; Hervouet et al. 2018). Therefore, we next assessed levels of DNA methylation by bisulfite PCR amplicon sequencing of regions within the Cd4 DMR. In agreement with our previous work, we observed demethylation from the DP thymocyte to the CD4+ T-cell stage and persistent DNA methylation within CD8+ T cells at the TSS and +1600 bp downstream in the first intron, adjacent to the regulatory elements S4 and the maturation enhancer (E4M) (Supplemental Fig. S3B,C; Sellars et al. 2015; Issuree et al. 2018; Kojo et al. 2018). We next assessed DNA methylation after CRISPR targeting of Dnmt3a by electroporating sgRNAs into Cas9Tg CD8+ T cells and could not detect an appreciable difference in methylation within the +1600 region of the DMR as compared with the Olfr2 targeted control in sorted CD8+CD4+ cells or in the bulk population that was combined with Chaf1a deficiency (Fig. 2B; Supplemental Fig. S3D).

To systematically address changes in DNA methylation and rule out the possibility that methylation changes occur at other important sites within the Cd4 locus, we performed whole-genome methylation analysis on DNA from CD8+CD4+ T cells after targeting Dnmt3a or Dnmt1 with electroporated sgRNA (Supplemental Fig. S3E). Consistent with the bisulfite PCR amplicon sequencing, there was little change in DNA methylation along the entirety of the Cd4 locus in CD8+CD4+ T cells after Dnmt3a targeting, with total levels of DNA methylation similar to those in Olfr2 targeted control CD8+CD4 T cells. In contrast, Dnmt1 targeting induced widespread hypomethylation in CD8+CD4+ T cells.

The contrasting roles of Dnmt1 and Dnmt3a in controlling DNA methylation in mature T cells led us to hypothesize that disabling the two classes of DNA methyltransferases would lead to enhanced Cd4 derepression. Consistent with our previous results (Sellars et al. 2015), in 3A3B KO CD8+ T cells, there was marked Cd4 derepression after Dnmt1 KD, suggesting that widespread DNA methylation remained an intact mechanism of repression at the Cd4 locus (Supplemental Fig. S4). Thus, given the lack of gross defects in DNA methylation after loss of Dnmt3a and the retained sensitivity to Dnmt1 inhibition in 3A3B KO cells, we explored whether Dnmt3a may influence Cd4 derepression through the effects of histone modifications, such as histone acetylation and deacetylation, prominent mechanisms of gene regulation (Jenuwein and Allis 2001). Treatment of 3A KO CD8+ T cells with the pan-HDAC inhibitor trichostatin A (TSA) potently enhanced Cd4 derepression (Fig. 2C). In contrast, there was only a modest effect of TSA on CD4 expression in WT CD8+ T cells, and this was not further accentuated by Dnmt1 deficiency (Fig. 2D). Taken together, these data support a role for Dnmt3a in repressing Cd4 expression at least in part through sensitizing cells to changes in histone modifications, such as histone acetylation.

CAF-1 and Dnmt1 regulate gene expression through distinct mechanisms

To further elucidate the connection between the DNA methyltransferases and CAF-1 in maintaining Cd4 silencing, we compared DNA methylation and chromatin accessibility in cells in which Cd4 derepression was achieved through KD of either Chaf1a or Dnmt1. As expected from the results following inactivation of both Chaf1a and Dnmt3a (Supplemental Fig. S3D), there was no appreciable change in demethylation after Chaf1a KD even in sorted cells that up-regulated CD4 expression (Fig. 3A; Supplemental Fig. S5A). The absence of DNA demethylation following CAF-1 deficiency was consistent with previous reports in Arabidopsis thaliana and a murine fibroblast cell line (Tchenio et al. 2001; Schönrock et al. 2006). In contrast, after Dnmt1 KD, we observed marked DNA demethylation, with greater demethylation correlating with Cd4 derepression.

Figure 3.

Figure 3.

CAF-1 deficiency induces Cd4 expression without significant changes in DNA methylation or chromatin accessibility. (A) Bisulfite PCR amplicon sequencing of the Cd4 +1600 region was performed after shRNA transduction and sorting of T cells of the indicated phenotype (two independent biological replicates are shown). The schematic shows the relative density of CpG dinucleotides assessed (open circles), and arrowheads indicate the +1600 region and regulatory elements S4 and E4M. (B) ATAC-seq tracks of the Cd4 locus of the indicated T-cell samples. The regulatory elements E4M and S4 are indicated by downward arrowheads. (C) Principal component analysis (PCA) of RNA-seq from CD8+ T cells transduced with the indicated shRNAs and sorted based on the indicated phenotypes. (D) Heat map depicting expression levels of selected CD4+ lineage genes in the indicated samples. (E) PCA of ATAC-seq from CD8+ T cells transduced with the indicated shRNAs and sorted based on the indicated phenotypes.

Since we did not detect changes in DNA methylation after CAF-1 deficiency, we used ATAC-seq to assess changes in chromatin accessibility, which was shown previously to be influenced by CAF-1 (Tchenio et al. 2001; Cheloufi et al. 2015). In the first intron of the Cd4 locus, CD4+ T cells have increased accessibility at E4M and decreased accessibility at S4 (Supplemental Fig. S5B). However, after Chaf1a KD in CD8+ T cells, we did not detect significant changes in accessibility in the first intron of cells in which Cd4 was derepressed, as compared with CD8+ T cells treated with control shRNA (Fig. 3B). In contrast, Dnmt1 KD led to reduced accessibility at the silencer element in CD8+ T cells, which resembled chromatin accessibility in CD4+ T cells (Fig. 3B). Consistent with a role for DNA methylation in altering chromatin accessibility at regulatory elements S4 and E4M, there was no notable change in CD8+CD4+ T cells after Dnmt3a sgRNA targeting (Supplemental Fig. S5C). It should be noted that there was a modest increase in accessibility at the Cd4 promoter after Dnmt3a targeting, which may reflect an alternative pathway to activation.

Because of the differences in DNA methylation and chromatin accessibility at the Cd4 locus following Chaf1a versus Dnmt1 KD, we sought to determine whether these changes were representative of genome-wide effects under each of these conditions. After sorting cells based on Cd4 derepression, we found that the CD8+ T-cell transcriptomes clustered according to shRNA treatment rather than CD4 expression status. The majority of differentially expressed genes relative to control shRenilla transduction were unique, indicating primarily nonoverlapping roles for both Chaf1a and Dnmt1 in CD8+ T cells (Fig. 3C). Chaf1a deficiency dysregulated more genes than Dnmt1, suggesting that DNA methylation had more limited effects on gene regulation relative to chromatin-mediated activities of CAF-1. Notably, the populations with CD4 derepression did not up-regulate characteristic genes of the CD4+ lineage (Fig. 3D). Furthermore, ATAC-seq samples clustered by shRNA treatment rather than CD4 expression and separately from CD4+ T helper cells (Fig. 3E). This suggests that the derepression of the Cd4 gene itself did not confer a change in accessibility sufficient to uniquely separate this population. Taken together, these results indicate that the CD8+ T cells that derepress Cd4 do not undergo lineage conversion.

Both Dnmt1 deficiency and Chaf1a deficiency were involved primarily in gene repression (Supplemental Fig. S6A). To gain more insight into the underlying mechanism, we next compared genome-wide the magnitude of change in gene expression with the corresponding magnitude of change in chromatin accessibility. We focused on genes that were divergently expressed following Chaf1a versus Dnmt1 KD and found that gene accessibility and expression correlated to a higher degree after deficiency of Dnmt1 compared with CAF-1, albeit with modest R2 values (Supplemental Fig. S6B). The modest correlation was likely due to several confounding factors, including small percentages of cells undergoing stochastic gene derepression, changes in accessibility of distal enhancers that could not be assigned to specific genetic loci, and complex forms of regulation occurring in trans. Notably, in both sets of data, there were examples of significant changes in gene expression with and without corresponding changes in accessibility (Supplemental Fig. S6C).

Characterization of Chaf1a domains involved in Cd4 silencing

To gain more insight into the mechanism used by CAF-1 to silence Cd4, we performed complementation assays with shRNA-resistant Flag-tagged Chaf1a constructs. We cotransduced retroviral shRNA and Chaf1a cDNA constructs into 3A KO CD8+ T cells to provide a larger signal to noise ratio. Full-length (FL) Chaf1a rescued Cd4 repression efficiently relative to empty vector (EV) (Fig. 4A). Previous studies identified N-terminal truncations of Chaf1a that were capable of rescuing essential CAF-1 function in vivo (Hoek et al. 2011). Other N-terminal truncations were shown to act as dominant-negative mutants that impaired gene repression and heterochromatin formation in mammalian cells (Tchenio et al. 2001; Reese et al. 2003). We assessed two N-terminal truncation mutants, referred to as T1 (amino acids 338–911) and T10 (amino acids 409–911) (Fig. 4B). T1 rescued Chaf1a deficiency equally well to FL Chaf1a (Fig. 4C). The rescue effect was specific to Chaf1a deficiency, as Dnmt1 KD was not rescued by ectopic expression of T1 or FL. Furthermore, T1 required the ED domain (glutamate-rich and aspartate-rich region) (Fig. 4B, green box), as its internal deletion abrogated rescue function without affecting its expression level (Supplemental Fig. S7A,B). Analysis of construct T10 showed that it possessed dominant-negative activity, as it enhanced Cd4 derepression in the context of Renilla or Dnmt1 KD (Fig. 4C) but did not further enhance derepression upon Chaf1a KD. The T10 protein, which lacks the KER domain, had a greatly reduced ability to interact with PCNA and histone H3 in transfected Plat-E cells but retained its association with CHAF1B relative to the FL and T1 molecules (Fig. 4D; Supplemental Fig. S7C).

Figure 4.

Figure 4.

PCNA binding and the KER region are required for Chaf1a-mediated repression of Cd4. (A) 3A KO CD8+ T cells were cotransduced with shRNA targeting Chaf1a (shChaf1a.3118) plus shRNA-resistant FL Chaf1a or EV control, and doubly transduced gated cells were evaluated for expression of CD4. (B) Schematic of domain organization of mouse FL Chaf1a protein, the rescue truncation (T1), and the dominant-negative truncation (T10). Flag tag was added to the C termini of all constructs (not depicted). Colored regions indicate the PCNA-interacting peptide 1 (PIP1; black), heterochromatin-associated protein 1 domain (red), PEST domain (gray), KER domain (orange), PIP2 (black), ED domain (green), and dimerization domain (“D,” blue). (C) 3A KO CD8+ T cells were cotransduced with the indicated retroviral shRNA and rescue constructs and assessed for CD4 expression. Data are means ± SD. n ≥ 4. (ns) Not statistically significant; (*) P < 0.05; (**) P < 0.01; (***) P < 0.001 by Student's t-test. (D) Immunoprecipitation of Flag-tagged Chaf1a constructs transfected into Plat-E cells and probed for the ability to pull down PCNA and CHAF1B. (E) CD4 expression after transduction of the indicated Chaf1a constructs into 3A KO CD8+ T cells. Data are representative of two independent experiments.

Chaf1a contains two PCNA-interacting peptide (PIP) motifs: PIP1 and PIP2. The N-terminal PIP1, absent in T1, was not required for rescue. PIP2 was shown to be essential for nucleosome assembly in vitro and for CAF-1 function in vivo (Rolef Ben-Shahar et al. 2009). Furthermore, its disruption was reported to result in interference with gene repression in yeast and in loss of PCNA binding (Krawitz et al. 2002). To determine the effect of disrupting the Chaf1a–PCNA interaction on Cd4 derepression, we assessed the function of a PIP2 mutation within the T1 backbone—T1-PIP2 (Chaf1a_F428A)—that was unable to rescue silencing (data not shown). This molecule showed dominant-negative activity in CD8+ T cells, conferring increased CD4 expression relative to EV or T1 (Fig. 4E). Similarly to T10, the T1-PIP2 protein retained association with the other subunits of CAF-1, suggesting that dominant-negative Chaf1a mutants may sequester endogenous CAF-1 subunits away from the replication fork, as hypothesized previously (Supplemental Fig. S7D; Tchenio et al. 2001; Ye et al. 2003). Interestingly, the T1-PIP2 construct had a less severe phenotype than T10 (which was also evident in WT CD8+ T cells) despite a similar loss in PCNA binding (Supplemental Fig. S7E). This suggests that additional functions of the KER region, such as potentially mediating histone binding (Supplemental Fig. S7C) or its recently reported role in DNA binding, might also be relevant for Cd4 silencing (Sauer et al. 2017). Thus, from our structure–function analysis, we conclude that both the PCNA interaction and the KER region are essential for Chaf1a to repress Cd4.

Chaf1a associates with histone-modifying enzymes that are also required for the maintenance of Cd4 silencing

CAF-1 is reported to contribute to the maintenance of heterochromatin integrity through its association with factors and enzymatic activities enriched at heterochromatin loci (Reese et al. 2003; Sarraf and Stancheva 2004; Heyd et al. 2011; Yang et al. 2015; Cheloufi and Hochedlinger 2017). Using the rescue and dominant-negative constructs T1 and T10, respectively, we screened for binding partners by mass spectrometry in transfected Plat-E cells. The top hits for T1 and T10 after subtracting the EV negative control pull-down were CHAF1B and RBBP4, the other two subunits of the CAF-1 complex (Fig. 5A; Supplemental Table 2). Interestingly, T1, but not T10, associated with HDAC1 and HDAC2 and the histone H3K4 demethylase LSD1, proteins within transcriptional corepressor complexes that are involved in removing active histone modifications (Delcuve et al. 2012). These protein associations were reported previously with the FL Chaf1a, and we confirmed their interactions with the T1 construct in transfected Plat-E cells (Fig. 5B; Heyd et al. 2011; Yang et al. 2015). These data suggest that the KER region is required for the interaction of Chaf1a with these epigenetic modifiers. Furthermore, the association of HDACs and LSD1 with T1 did not occur indirectly through PCNA, as it was observed even with the PCNA-binding mutant T1-PIP2.

Figure 5.

Figure 5.

Chaf1a associates with histone-modifying enzymes that are required for the maintenance of Cd4 silencing in CD8+ T cells. (A) Immunoprecipitation-mass spectrometry results from anti-Flag pull-down of extracts from Plat-E cells transfected with EV and T1 and T10 constructs. T1 and T10 were plotted with EV subtracted as background. CAF-1 components shared between T1 and T10 and repressive histone-modifying enzymes specific for the T1 rescue construct are highlighted in maroon. (B) Flag pull-down from transfected Plat-E cells, blotted for the histone-modifying enzymes shown in A. (C) Retroviral sgRNA constructs were transduced into Cas9Tg or 3A KO Cas9Tg CD8+ T cells, and CD4 expression was assessed. Data are means ± SD. n ≥ 4. (*) P < 0.05; (**) P < 0.01 by Student's t-test. (D). Histone modifications were assessed in sorted CD8+CD4+ T cells adjacent to the Cd4 TSS after shRNA KD of Chaf1a (shChaf1a.3118) or in sorted CD8+CD4 T cells after control transduction (shRenilla.713). Data are averaged from two biological replicates.

We next assessed whether these histone-modifying enzymes function in the maintenance of Cd4 silencing by targeting their genes with sgRNAs in Dnmt3a-sufficient or 3A KO CD8+ T cells. Modest CD4 up-regulation occurred after targeting Hdac1 or Lsd1 in Dnmt3a-sufficient cells, and this was substantially enhanced in the absence of Dnmt3a (Fig. 5C). Similarly, pharmacological inhibition of LSD1 showed Dnmt3a-dependent enhancement (Supplemental Fig. S8). Finally, to determine whether CAF-1 deficiency may affect the histone modification status imposed by HDACs and LSD1, we assessed by ChIP-qPCR for the presence of H3K9ac and H3K4me2 as well as for H3K4me3, a modification that marks active promoters (Fig. 5D). After Chaf1a KD, CD8+ T cells that had up-regulated CD4 also had increased levels of H3K4me3, H3K9ac, and H3K4me2. Thus, CAF-1 deficiency leads to increased levels in active histone modifications at the Cd4 locus. These data indicate that CAF-1 enables removal of “active” or “permissive” marks at the Cd4 locus, potentially by promoting the deacetylase and demethylase activities of HDACs and LSD1, respectively.

Discussion

The discovery that sustained Cd4 silencing in mature T cells is independent from the DNA sequence required for its establishment led to the proposal that epigenetic factors were involved in maintaining the repressed state (Zou et al. 2001). Both DNA and histone modification-based mechanisms of Cd4 silencing have been invoked, but their potential cooperation and cross-talk were not explored (Sellars et al. 2015; Verbaro et al. 2018). In this study, we used shRNA and sgRNA screening to identify chromatin-associated factors that repress Cd4 expression in mature CD8+ T cells. We further characterized their relationships with the DNA methyltransferases, enzymes identified previously as mediating the maintenance of Cd4 silencing (Henson et al. 2014; Sellars et al. 2015). Although we focused on the replication-coupled H3–H4 histone chaperone CAF-1, we also found additional Cd4 repressors in our candidate sgRNA screen, including the chromatin remodeling enzyme Smarca5 and the replicative helicase component Mcm2. Like CAF-1, the repressive capacity of these factors in silencing Cd4 was potentiated by Dnmt3a, suggesting a general role for replication fork-associated factors and the de novo DNA methyltransferases in gene regulation. Future study of additional factors that participate in Cd4 repression based on our candidate screening may help in further understanding the relationship between chromatin-based and DNA-based mechanisms of heritable transcriptional silencing.

Investigation of combined Dnmt1 and CAF-1 deficiency revealed modest but reproducible enhancement of Cd4 derepression. CAF-1 and Dnmt1 deficiencies showed differences with respect to alterations in chromatin accessibility and DNA methylation at the Cd4 locus. These distinct effects of Dnmt1 and CAF-1 deficiencies were mirrored in their unique gene expression profiles. Interestingly, in contrast to thymic deficiency in the absence of histone methyltransferase G9a, another maintenance factor in Cd4 silencing, we did not observe a CD4+ lineage-like phenotype in CD8+ T cells that had up-regulated CD4 (Verbaro et al. 2018). This may reflect differences in the studies, as we targeted the genes in mature cells after thymic maturation. Conditional deletion of CAF-1 components during development followed by transcriptomic analysis will help determine any potential relationship between CAF-1 and G9a activities.

In contrast to Chaf1a KD or Dnmt3a targeting, reduced Dnmt1 resulted in hypomethylation of the Cd4 DMR, whose extent correlated with CD4 up-regulation. The intermediate DNA methylation level after Dnmt1 KD seen in CD4 cells may indicate that there is a threshold of DNA demethylation that is required for Cd4 derepression. Alternatively, targeted CD4 and CD4+ cells may be equally prone to derepression, and further demethylation in the derepressed fraction may be a consequence of transcription, as noted in other contexts (Bestor et al. 2015). Interestingly, our recent study found that failure to demethylate the Cd4 locus during CD4+ T-cell development due to TET enzyme deficiency resulted in unstable CD4 expression in activated helper T cells but did not affect expression of CD4 in CD4SP thymocytes (Issuree et al. 2018). Thus, DNA demethylation at the Cd4 locus may not be involved in establishing CD4 expression but rather may serve to stabilize its expression state during cell division.

Dnmt1 KD also induced Cd4 locus accessibility resembling that in CD4+ helper T cells, and this effect was more pronounced in the CD4+ fraction in a fashion analogous to the increased DNA demethylation observed in this population. Although the functional consequences of DNA methylation altering the chromatin landscape of S4 and E4M are unclear, nucleosome positioning in the first intron of Cd4 was found to correlate with its expression status (Sellars et al. 2015). Additionally, such changes in chromatin accessibility may modulate the stability of Cd4 derepression despite our previous finding that this region is dispensable for heritable silencing (Zou et al. 2001). In this regard, testing Cd4 expression levels over time after induction of CAF-1 or Dnmt1 deficiency will be informative. Interestingly, Dnmt3a deficiency did not incurr either significant demethylation or notable changes in chromatin accessibility, lending further support to the hypothesis that the accessibility in the first intron of the Cd4 locus is sensitive to methylation status.

In our analysis of Cd4 silencing, we found strong synergies in Cd4 derepression when Dnmt3 and CAF-1 deficiencies were combined. We found previously that several cytosine residues acquired de novo methylation—likely due to Dnmt3 enzymatic activity—during progression from the DP to the CD8SP stage (Sellars et al. 2015). Here, we observed that Dnmt3 activity was also required for Cd4 silencing in peripheral CD8+ T cells. Unexpectedly, we could not observe significant changes in DNA methylation in mature CD8+ T cells that had up-regulated Cd4 expression after targeting Dnmt3a or in cells that were doubly deficient with Chaf1a. Furthermore, Dnmt1 KD in 3A3B KO cells potently up-regulated CD4 expression, a finding consistent with the interpretation that, in the absence of the Dnmt3 enzymes, methylated CpGs were still available to be passively demethylated, with consequent Cd4 derepression. However, as the catalytic domain of Dnmt3a was required for rescuing 3A KO CD8+ T cells, there may be individual CpG residues affected that hold disproportionate importance for Cd4 repression (although full-genome methylation sequencing revealed no obvious loss of methylation at any residues within the locus), or there may be indirect effects from the up-regulation of other factors that can promote Cd4 expression. Alternatively, the mutation of the Dnmt3a catalytic domain may alter its interaction with binding partners, as has been reported with DNMT3A R882 mutants, and this may subsequently influence the heritable silencing of Cd4 independently of changes in DNA methylation (Koya et al. 2016).

The specific sensitization of Dnmt3a-deficient CD8+ T cells to Cd4 derepression upon treatment with histone-modifying drugs or genetic targeting of Chaf1a-associated histone-modifying enzymes suggests a functional coupling of Dnmt3a to the regulation of histone modifications. Although we focused on the removal or prevention of activating histone modifications, another possibility is that Dnmt3a facilitates repressive histone marks that counteract the activating effects of histone acetylation and H3K4 methylation. Also, as is the case with DNA methylation, the extent of a transcriptionally instructive role for histone modifications remains uncertain (Ptashne 2013). In light of the increased H3K4 methylation and H3K9 acetylation induced by CAF-1 deficiency and strong correlation with CD4 induction, the Cd4 locus may be a good model to test for potential instructive and heritable functions of these modifications, such as by conditionally and specifically targeting histone-modifying enzymes, now made feasible with gene-editing tools.

To gain more insight into the mechanism by which CAF-1 participates in gene silencing, we identified domains of the protein that are critical for its repressive function. We identified N-terminal truncations that either can rescue or have dominant-negative function in the repression of Cd4. This allowed us to use mass spectrometry to identify binding partners specific to our rescue-competent and dominant-negative mutants. We found that the KER region, but not the PIP2 motif, was required for the association of Chaf1a with multiple histone-modifying enzymes, including the HDACs HDAC1/2 and histone demethylase LSD1. CRISPR targeting of these molecules led to Cd4 up-regulation that was significantly potentiated by Dnmt3a deficiency, emphasizing the connection of Dnmt3a to the regulation of histone modifications. However, compared with the targeting of Chaf1a, we could not achieve similar levels of Cd4 derepression when targeting Lsd1 or Hdac1 individually. This likely reflects in part the combinatorial functions of these and potentially other CAF-1-associated enzymes. Deficiency of CAF-1-mediated nucleosome assembly may also affect gene repression in an indirect manner that is not mutually exclusive to its role in recruiting histone-modifying enzymes. For example, defective nucleosome assembly by CAF-1 could lead to compensatory recruitment of the histone variant H3.3, which has been suggested to participate in gene activation (Ray-Gallet et al. 2011; Weber and Henikoff 2014). As reported previously for gene repression in yeast, we found that association with PCNA was critical for CAF-1-mediated Cd4 repression, specifically through the internal PIP2 motif, which is required for recruitment to replication foci and replication-coupled nucleosome assembly (Krawitz et al. 2002; Rolef Ben-Shahar et al. 2009; Zhang et al. 2016). Similarly, we found that the KER region, a predicted coiled-coil domain, was also required for Chaf1a-mediated silencing. This may be due to its roles in nucleosome assembly and in mediating DNA binding, as shown recently for the yeast homolog of Chaf1a (Sauer et al. 2017). In future studies, it will be important to distinguish KER-mediated recruitment of histone-modifying enzymes from its function in chromatin assembly by using mutants specifically disabling each activity.

The Cd4 locus serves as a model to investigate the heritable repression of alternative lineage genes in primary somatic cells. In this study, we found a novel connection between CAF-1, repressive histone-modifying enzymes, and DNA methylation in the repression of the alternative lineage gene Cd4 in CD8+ T cells. We delineated maintenance roles in Cd4 silencing for both Dnmt3a and Dnmt1 and found unique synergy between Dnmt3a and CAF-1 that involved the inhibition of gene activation-associated histone acetylation and methylation. Thus, we propose that chromatin-based mechanisms of silencing through CAF-1 and histone-modifying enzymes collaborate with the DNMTs in the repression of Cd4 (Supplemental Fig. S9). Given the evolutionarily conserved role of CAF-1 in the maintenance of heterochromatin and cell identity, further clarifying how it functions at the crossroads with other epigenetic pathways will likely provide important insight into gene regulation, differentiation, and development.

Materials and methods

Mice

Cd4-Cre, Dnmt1chip, Dnmt3af/f , and Dnmt3bf/f mouse strains were described previously (Lee et al. 2001; Sellars et al. 2015). Mice harboring the Cas9 transgene (Cas9Tg) were purchased from Jackson Laboratories. The Cas9 strains with constitutive (stock no. 026179) or conditional (stock no. 026175 and crossed to Cd4-Cre) expression of Cas9 were used interchangeably. Experiments were performed on male and female mice age 6–12 wk. All mice were maintained in the animal facility at the Skirball Institute. Experiments with animals were conducted according to approved protocols for the New York University Institutional Animal Care and Usage Committee.

Primers and antibodies

All primers and antibodies are listed in Supplemental Table 3.

Plasmids and rescue experiments

The retroviral sgRNA expression vector pSIN-U6-sgRNA-EF1as-Thy1.1-P2A-Neo was generated by mutating a pSIN vector backbone and the 5′ LTR to remove BbsI sites and assembling a hU6-BbsI-filler-BbsI-tracr EF1as-Thy1.1-P2A-Neo cassette downstream from the packaging signal, and shRNA vectors LENG (MSCV-miRE-pgk-Neo-IRES-GFP) and LENC (MSCV-miRE-pgk-Neo-IRES-mCherry) have been described previously (Fellmann et al. 2013). For rescue experiments, murine Chaf1a cDNA or Dnmt3a cDNA was cloned into an MSCV-IRES-Thy1.1 retroviral vector. The catalytic-dead Dnmt3a mutant was made using Gibson (New England Biolabs), where the V712 codon, equivalent to human V716, was mutated (Zhang et al. 2018). Flag tag (amino acids DYKDDDDK) was added to the C termini and N termini of Chaf1a and Dnmt3a rescue constructs, respectively. For the T1-ED construct, the ED domain (amino acids 518–613) was replaced with a Gly–Ser–Gly–Ser linker. Rescue constructs were transduced into 3A KO CD8+ T cells interchangeably with 3A KO Cas9Tg CD8+ T cells.

In vitro culture of CD8+ T cells and retroviral transduction

T cells were isolated from mouse spleen and lymph nodes and purified by positive selection with MACS anti-CD8 magnetic beads according to the manufacturer's protocol (Miltenyi Biotech) or by cell sorting for naïve cells (TCRβ+CD8+CD25CD62L+CD44) on FACSAria (BD Biosciences). For T-cell activation, wells were precoated with 1 mg/mL goat antihamster IgG at 1:40 dilution (MP Biomedicals). T cells were resuspended in T-cell medium (TCM): RPMI (Fisher Scientific) supplemented with 10% FBS (Atlanta Biologicals), 4 mM glutamine, 50 μM β-mercaptoethanol, and 20 mM HEPES. For activation, TCM was further supplemented with 1 µg/mL anti-CD3 (Bio X Cell) and 1 µg/mL anti-CD28 (Bio X Cell). After overnight activation, T cells were transduced by spin infection with retroviral particles with 10 µg/mL polybrene (Sigma). Spin infection was performed by centrifugation at 850g for 1.5 h at 32°C. T cells were kept in TCM supplemented with 100 U/mL human IL-2 (Peprotech) for 4–6 d prior to analysis for CD4 expression.

shRNA screen

An shRNA library focused on 625 epigenetic regulators was cloned into the LENG vector and used to generate a retroviral pool for infection (Cheloufi et al. 2015). CD8+ T cells were isolated from the spleens and lymph nodes of C57BL/6 (WT) mice by MACS anti-CD8 magnetic beads (Miltenyi), activated as described above, and cultured an additional 6 d prior to cell sorting. DNA was extracted by standard methods, and barcoded sequencing libraries were prepared using a nested PCR strategy with AmpliTAQ Gold polymerase (Thermo Fisher): 20 PCR cycles using primers MA389 and MA391 followed by a secondary PCR for 25 cycles with barcoding primers. The resulting libraries were submitted for Illumina SR50 sequencing. Average reads in each of the three replicates corresponding to each shRNA in each fraction were used to determine enrichment.

Retrovirus production

The Plat-E cell line was used to prepare ecotropic retroviral particles for T-cell transduction using Mirus (Mirus Bio) or jetPRIME (Polyplus) transfection reagents (Morita et al. 2000).

Electroporation of sgRNA amplicons

Naïve Cas9Tg CD8+ T cells were sorted and immediately electroporated with 4D-Nucleofector (Lonza) using 0.5 µg of sgRNA amplicon obtained by PCR amplification from retroviral sgRNA vector. After electroporation, cells were activated for 48 h, transduced with the indicated retroviral sgRNAs (as described above), and cultured in TCM supplemented with IL-2 (as described above) for another 48–72 h before analysis.

HDAC and LSD1 inhibitor treatment

TSA (HDAC inhibitor; Sigma), GSK2879552 (LSD1 inhibitor; Cayman Chemical), or DMSO was added to T cells after 4 d of culture and analyzed either 24 or 48 h later by flow cytometry.

Bisulfite PCR sequencing

DNA was isolated from T cells using either phenol–chloroform extraction or Qiagen DNEasy kit. Purified genomic DNA was subjected to bisulfite treatment with the Qiagen EpiTect bisulfite kit and PCR-amplified with KAPA Taq DNA polymerase (Kapa Biosystems). The PCR amplicon coordinates shown are relative to the mm9 genome. Amplicons were TA-cloned using pGEM-T Easy Vector systems (Promega) and transformed into Stbl3 bacteria for subsequent plasmid extraction with Qiagen Spin Miniprep kit followed by sequencing. Analysis of Sanger-sequenced clones was performed with QUMA (Kumaki et al. 2008).

Whole-genome DNA methylation sequencing

DNA was isolated from T cells using phenol–chloroform extraction. For each sample, 100 ng of input DNA was sheared with a Covaris LE220 instrument aiming for 450-bp fragments. Sheared DNA was prepared with an EM-Seq kit (New England Biolabs) following the manufacturer's instructions. Briefly, the treatment included a TET2-mediated oxidation of 5mCs to 5hmCs. This was followed by APOBEC cytosine deaminase treatment, resulting in conversion of unmethylated cytosines to uracil and their appearance as thymidines in the final sequencing data. Methylated and hydroxymethylated cytosines were indistinguishable from each other and were present as cytosines in the sequencing data. Unmethylated (λ) and fully CpG methylated (pUC19) DNA were spiked into each sample and used as internal control for conversion efficiencies. The final sequencing libraries were amplified with four cycles of PCR, and libraries were sequenced on Illumina HiSeqX targeting 30× coverage per sample. After sequencing, the FASTQ files were processed as follows: Adapter sequences (Illumina TruSeq, “AGATCGAAGAGAC”) were hard-clipped from raw paired-end FASTQs using Trim Galore version 0.4.4 (https://github.com/FelixKrueger/TrimGalore). The resulting reads were then aligned with default parameters for bwa-meth (https://github.com/brentp/bwa-meth) to a reference genome comprised of concatenated mm10, pUC19, and λ sequences, with the exception of inclusion of the “bwa mem -Y” flag and flagging of quality control-failed reads (0 × 200 flag) when alignment length was <0.2× read length. Aligned BAMs were split into separate mm10, pUC19, or BAMs for downstream analysis. These split BAMs were duplicate-marked using Picard version 2.8.0 (http://broadinstitute.github.io/picard). Methylation genotyping was performed on each using MethylDackel version 0.1.13 (https://github.com/dpryan79/MethylDackel). Methylation sequencing was deposited in the Gene Expression Omnibus (GEO) database under accession number GSE126472.

ATAC-seq

Samples were prepared as described (Buenrostro et al. 2013). Briefly, WT or Cas9Tg T cells were activated and transduced with retroviral shRNA constructs or electroporated with sgRNA, respectively. After five additional days of culture, 50,000 cells were sorted based on CD8 and CD4 expression. Cells were washed, nuclei were isolated, and libraries were submitted to the New York University Langone Genome Technology Center for sequencing. Fastq files were obtained from 50-bp paired-end reads and analyzed by aligning reads to the mm9 genome with Bowtie2 using default settings on the Galaxy platform (Afgan et al. 2018). The resulting BAM files were filtered for PCR duplicates (using sambamba), mitochondrial DNA alignments, MAPQ <30 alignment quality, ENCODE blacklisting, and imperfect paired-end reads. Filtered BAM files were down-sampled when possible to ∼13 million filter-aligned reads, the third lowest complexity-filtered BAM file size, before visualization on Integrative Genomics Viewer by generating bigWig files with bamCoverage on default settings on the Galaxy platform (Robinson et al. 2011). ATAC-seq data were deposited in the GEO database under accession number GSE126472.

RNA-seq

T-cell samples were cultured in the same way as ATAC-seq (above). RNA was isolated from cells sorted into TRIzol (Invitrogen) followed by treatment with DNase I and cleanup with RNeasy MinElute kit (Qiagen). T-cell RNA libraries were prepared with Nugen Ovation Ultralow library system V2 by HudsonAlpha. Sequencing was performed with Illumina HiSeq 2500 version 4. FASTQ files were processed through kallisto using an mm10 kallisto index from an ENSEMBL GTF annotation file. Count estimates from kallisto were extracted and aggregated to gene-level counts by summation. Principal component analysis (PCA) was conducted using prcomp on a CPM matrix filtered for genes that had >5 CPM in at least two samples. Differential expression analysis was conducted on the entire count matrix using voom and limma, with an additive model for the main perturbational effect (i.e., shDnmt1) and the CD4+ effect to control for variability seen in the PCA. Differential expression genes were considered with an FDR of <0.05 (Benjamini-Hochberg-corrected P-value) and an absolute log2(fold change) of >1. RNA-seq data were deposited into the GEO database under accession number GSE126472.

Combined genome-wide analysis of ATAC-seq and RNA-seq

Differentially expressed genes from RNA-seq described above were used for analysis as follows: ATAC-seq peaks and reads within those peaks were annotated to the nearest gene TSS within 30 kb using the Bedtools closest command. Unannotated peaks were discarded. Reads within peaks were then aggregated down to gene level by summation, and differential expression analysis was annotated as with RNA-seq and plotted by log10 fold change.

Western blotting

For Western blotting, samples were transferred from polyacrylamide gel to nitrocellulose membrane by wet transfer for 4 h on ice at 60 V. Blots were blocked in PBS blocking buffer (Licor) and then stained overnight with primary antibody at 4°C. The next day, membranes were washed three times in PBST (PBS and 0.1% Tween-20), stained with fluorescently conjugated secondary antibodies (Licor) at 1:10,000 dilution in PBS blocking buffer for 1 h at room temperature, and then imaged in the 680- and 800-nm channels.

Flag tag coimmunoprecipitation and mass spectrometry

Transfected Plat-E cells were cultured for 48–72 h, detached from 10-cm dishes by pipetting, and subsequently washed in PBS. Nuclei were isolated by resuspending cell pellets in 500 µL of IPMS buffer (0.5% NP-40, 100 mM NaCl, Tris-HCl at pH 8.0, 1× protease inhibitor [Sigma]) and rotating for 30 min at 4°C. Samples were homogenized by passing through a 23.5-gauge needle 10–15 times. Cellular debris was spun down, and the supernatant was precleared with protein A beads (Dyna beads) for 1 h prior to incubation with 10 µg of Flag antibody overnight at 4°C with rotation. For samples used to assess for histone binding (Supplemental Fig. S8C), 0.625 µg of human recombinant H3.1–H4 tetramer (New England Biolabs) was spiked in. The next day, protein-bound beads were washed five times in IPMS buffer, and bound proteins were eluted by boiling samples in loading buffer. Samples were either submitted to New York University School of Medicine Proteomics Laboratory for mass spectrometry or used for Western blot. The mass spectrometry proteomics data were deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the data set identifier PXD012669 (Perez-Riverol et al. 2019).

ChIP-qPCR

T cells were transduced and cultured for 5 d. Next, 100,000 CD8+CD4 shRenilla.713-treated or CD8+CD4+ shChaf1a.3118-treated T cells were isolated by cell sorting and processed for ultralow input micrococcal nuclease-based native ChIP (ULI-NChIP) (Brind'Amour et al. 2015). For immunoprecipitation, 3 µg of antibody was used per reaction. Immunoprecipitated and input DNA were used for qPCR with SYBR Green 2× master mix (Roche).

Cell sorting and flow cytometry

Samples were FACS-sorted on a FACSAria (BD Biosciences). Flow cytometry was performed on an LSRII (BD Biosciences), and analysis was performed using Flowjo (Treestar).

Supplementary Material

Supplemental Material

Acknowledgments

We are grateful to Richard Myers and colleagues at HudsonAlpha for RNA-seq, Adriana Heguy at New York University (NYU) School of Medicine's Genome Technology Center (GTC) for ATAC-seq, Beatrix Ueberheide at the NYU Proteomics Core for mass spectrometry, and the Research Institute of Molecular Pathology (IMP) Core Facilities for next-generation sequencing of the shRNA screen. The GTC and Proteomics Cores are supported by Cancer Center Support grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center, and the IMP is supported by Boehringer-Ingelheim. We are also grateful to John Greally and members of his laboratory (Albert Einstein College of Medicine) for help with whole-genome methylation sequencing. C.N. was supported by Immunology and Inflammation Training grant 5T32AI100853. M.A. was supported by a Marie Curie individual fellowship and an EMBO long-term fellowship. J.Z. was supported by a starting grant of the European Research Council (ERC-StG-336860). G.A. was supported by ERC-2015-ADG project 694694 ChromADICT from the European Research Council. D.R.L. is an Investigator of the Howard Hughes Medical Institute.

Author contributions: C.N. performed and analyzed all experiments. C.N. and D.R.L. designed experiments and analyzed the data. M.A. and J.Z. contributed to design and execution of shRNA and sgRNA screening. L.W. assisted with sgRNA electroporation. C.A. and T. Najar performed protein purification and Western blotting. B.H. and W.L. performed whole-genome methylation sequencing and analysis. T. Nguyen performed bioinformatics analysis. K.R.M., J.-P.Q., and G.A. participated in experimental design and manuscript preparation. C.N. and D.R.L. wrote the manuscript with input from other authors. D.R.L. supervised all research.

Footnotes

Supplemental material is available for this article.

Article published online ahead of print. Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.322024.118.

References

  1. Afgan E, Baker D, Batut B, van den Beek M, Bouvier D, Čech M, Chilton J, Clements D, Coraor N, Grüning BA, et al. 2018. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res 46: W537–W544. 10.1093/nar/gky379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bannister AJ, Kouzarides T. 2011. Regulation of chromatin by histone modifications. Cell Res 21: 381–395. 10.1038/cr.2011.22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barau J, Teissandier A, Zamudio N, Roy S, Nalesso V, Hérault Y, Guillou F, Bourc'his D. 2016. The DNA methyltransferase DNMT3C protects male germ cells from transposon activity. Science 354: 909–912. 10.1126/science.aah5143 [DOI] [PubMed] [Google Scholar]
  4. Bestor TH, Edwards JR, Boulard M. 2015. Notes on the role of dynamic DNA methylation in mammalian development. Proc Natl Acad Sci 112: 6796–6799. 10.1073/pnas.1415301111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brind'Amour J, Liu S, Hudson M, Chen C, Karimi MM, Lorincz MC. 2015. An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations. Nat Commun 6: 6033 10.1038/ncomms7033 [DOI] [PubMed] [Google Scholar]
  6. Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. 2013. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods 10: 1213–1218. 10.1038/nmeth.2688 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cedar H, Bergman Y. 2009. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10: 295–304. 10.1038/nrg2540 [DOI] [PubMed] [Google Scholar]
  8. Cheloufi S, Hochedlinger K. 2017. Emerging roles of the histone chaperone CAF-1 in cellular plasticity. Curr Opin Genet Dev 46: 83–94. 10.1016/j.gde.2017.06.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheloufi S, Elling U, Hopfgartner B, Jung YL, Murn J, Ninova M, Hubmann M, Badeaux AI, Euong Ang C, Tenen D, et al. 2015. The histone chaperone CAF-1 safeguards somatic cell identity. Nature 528: 218–224. 10.1038/nature15749 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chong MM, Simpson N, Ciofani M, Chen G, Collins A, Littman DR. 2010. Epigenetic propagation of CD4 expression is established by the Cd4 proximal enhancer in helper T cells. Genes Dev 24: 659–669. 10.1101/gad.1901610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Delcuve GP, Khan DH, Davie JR. 2012. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics 4: 5 10.1186/1868-7083-4-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dohke K, Miyazaki S, Tanaka K, Urano T, Grewal SI, Murakami Y. 2008. Fission yeast chromatin assembly factor 1 assists in the replication-coupled maintenance of heterochromatin. Genes Cells 13: 1027–1043. 10.1111/j.1365-2443.2008.01225.x [DOI] [PubMed] [Google Scholar]
  13. Fellmann C, Hoffmann T, Sridhar V, Hopfgartner B, Muhar M, Roth M, Lai DY, Barbosa IA, Kwon JS, Guan Y, et al. 2013. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep 5: 1704–1713. 10.1016/j.celrep.2013.11.020 [DOI] [PubMed] [Google Scholar]
  14. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, Silva AJ, Fan G. 2010. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 13: 423–430. 10.1038/nn.2514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Henson DM, Chou C, Sakurai N, Egawa T. 2014. A silencer-proximal intronic region is required for sustained CD4 expression in postselection thymocytes. J Immunol 192: 4620–4627. 10.4049/jimmunol.1302374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hervouet E, Peixoto P, Delage-Mourroux R, Boyer-Guittaut M, Cartron PF. 2018. Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma. Clin Epigenetics 10: 17 10.1186/s13148-018-0450-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Heyd F, Chen R, Afshar K, Saba I, Lazure C, Fiolka K, Möröy T. 2011. The p150 subunit of the histone chaperone Caf-1 interacts with the transcriptional repressor Gfi1. Biochim Biophys Acta 1809: 255–261. 10.1016/j.bbagrm.2011.04.009 [DOI] [PubMed] [Google Scholar]
  18. Hoek M, Myers MP, Stillman B. 2011. An analysis of CAF-1-interacting proteins reveals dynamic and direct interactions with the KU complex and 14-3-3 proteins. J Biol Chem 286: 10876–10887. 10.1074/jbc.M110.217075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Houlard M, Berlivet S, Probst AV, Quivy JP, Héry P, Almouzni G, Gérard M. 2006. CAF-1 is essential for heterochromatin organization in pluripotent embryonic cells. PLoS Genet 2: e181 10.1371/journal.pgen.0020181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Huang H, Yu Z, Zhang S, Liang X, Chen J, Li C, Ma J, Jiao R. 2010. Drosophila CAF-1 regulates HP1-mediated epigenetic silencing and pericentric heterochromatin stability. J Cell Sci 123: 2853–2861. 10.1242/jcs.063610 [DOI] [PubMed] [Google Scholar]
  21. Huang H, Strømme CB, Saredi G, Hödl M, Strandsby A, González-Aguilera C, Chen S, Groth A, Patel DJ. 2015. A unique binding mode enables MCM2 to chaperone histones H3-H4 at replication forks. Nat Struct Mol Biol 22: 618–626. 10.1038/nsmb.3055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ishiuchi T, Enriquez-Gasca R, Mizutani E, Bošković A, Ziegler-Birling C, Rodriguez-Terrones D, Wakayama T, Vaquerizas JM, Torres-Padilla ME. 2015. Early embryonic-like cells are induced by downregulating replication-dependent chromatin assembly. Nat Struct Mol Biol 22: 662–671. 10.1038/nsmb.3066 [DOI] [PubMed] [Google Scholar]
  23. Issuree PD, Ng CP, Littman DR. 2017. Heritable gene regulation in the CD4:CD8 T cell lineage choice. Front Immunol 8: 291 10.3389/fimmu.2017.00291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Issuree PD, Day K, Au C, Raviram R, Zappile P, Skok JA, Xue HH, Myers RM, Littman DR. 2018. Stage-specific epigenetic regulation of CD4 expression by coordinated enhancer elements during T cell development. Nat Commun 9: 3594 10.1038/s41467-018-05834-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jenuwein T, Allis CD. 2001. Translating the Histone Code. Science 293: 1074–1080. 10.1126/science.1063127 [DOI] [PubMed] [Google Scholar]
  26. Kaufman PD, Kobayashi R, Kessler N, Stillman B. 1995. The p150 and p60 subunits of chromatin assembly factor I: a molecular link between newly synthesized histones and DNA replication. Cell 81: 1105–1114. 10.1016/S0092-8674(05)80015-7 [DOI] [PubMed] [Google Scholar]
  27. Kojo S, Yasmin N, Muroi S, Tenno M, Taniuchi I. 2018. Runx-dependent and silencer-independent repression of a maturation enhancer in the Cd4 gene. Nat Commun 9: 3593 10.1038/s41467-018-05803-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Koya J, Kataoka K, Sato T, Bando M, Kato Y, Tsuruta-Kishino T, Kobayashi H, Narukawa K, Miyoshi H, Shirahige K, et al. 2016. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat Commun 7: 10924 10.1038/ncomms10924 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Krawitz DC, Kama T, Kaufman PD. 2002. Chromatin assembly factor I mutants defective for PCNA binding require Asf1/Hir proteins for silencing. Mol Cell Biol 22: 614–625. 10.1128/MCB.22.2.614-625.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kumaki Y, Oda M, Okano M. 2008. QUMA: quantification tool for methylation analysis. Nucleic Acids Res 36: W170–W175. 10.1093/nar/gkn294 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Pérez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, et al. 2001. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763–774. 10.1016/S1074-7613(01)00227-8 [DOI] [PubMed] [Google Scholar]
  32. Li E, Zhang Y. 2014. DNA methylation in mammals. Cold Spring Harb Perspect Biol 6: a019133 10.1101/cshperspect.a019133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Morita S, Kojima T, Kitamura T. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063–1066. 10.1038/sj.gt.3301206 [DOI] [PubMed] [Google Scholar]
  34. Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, Inuganti A, Griss J, Mayer G, Eisenacher M, et al. 2019. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47: D442–D450. 10.1093/nar/gky1106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Poot RA, Bozhenok L, van den Berg DL, Steffensen S, Ferreira F, Grimaldi M, Gilbert N, Ferreira J, Varga-Weisz PD. 2004. The Williams syndrome transcription factor interacts with PCNA to target chromatin remodelling by ISWI to replication foci. Nat Cell Biol 6: 1236–1244. 10.1038/ncb1196 [DOI] [PubMed] [Google Scholar]
  36. Ptashne M. 2013. Epigenetics: core misconcept. Proc Natl Acad Sci 110: 7101–7103. 10.1073/pnas.1305399110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Quivy J-P, Gérard A, Cook AJL, Roche D, Almouzni G. 2008. The HP1–p150/CAF-1 interaction is required for pericentric heterochromatin replication and S-phase progression in mouse cells. Nat Struct Mol Biol 15: 972–979. 10.1038/nsmb.1470 [DOI] [PubMed] [Google Scholar]
  38. Ray-Gallet D, Woolfe A, Vassias I, Pellentz C, Lacoste N, Puri A, Schultz DC, Pchelintsev NA, Adams PD, Jansen LE, et al. 2011. Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol Cell 44: 928–941. 10.1016/j.molcel.2011.12.006 [DOI] [PubMed] [Google Scholar]
  39. Reese BE, Bachman KE, Baylin SB, Rountree MR. 2003. The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1. Mol Cell Biol 23: 3226–3236. 10.1128/MCB.23.9.3226-3236.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. 2011. Integrative genomics viewer. Nat Biotechnol 29: 24–26. 10.1038/nbt.1754 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Roelens B, Clémot M, Leroux-Coyau M, Klapholz B, Dostatni N. 2017. Maintenance of heterochromatin by the large subunit of the CAF-1 replication-coupled histone chaperone requires its interaction with HP1a through a conserved motif. Genetics 205: 125–137. 10.1534/genetics.116.190785 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rolef Ben-Shahar T, Castillo AG, Osborne MJ, Borden KL, Kornblatt J, Verreault A. 2009. Two fundamentally distinct PCNA interaction peptides contribute to chromatin assembly factor 1 function. Mol Cell Biol 29: 6353–6365. 10.1128/MCB.01051-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sarraf SA, Stancheva I. 2004. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell 15: 595–605. 10.1016/j.molcel.2004.06.043 [DOI] [PubMed] [Google Scholar]
  44. Sauer PV, Timm J, Liu D, Sitbon D, Boeri-Erba E, Velours C, Mücke N, Langowski J, Ochsenbein F, Almouzni G, et al. 2017. Insights into the molecular architecture and histone H3–H4 deposition mechanism of yeast Chromatin assembly factor 1. Elife 6: e23474 10.7554/eLife.23474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sawada S, Scarborough JD, Killeen N, Littman DR. 1994. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell 77: 917–929. 10.1016/0092-8674(94)90140-6 [DOI] [PubMed] [Google Scholar]
  46. Schönrock N, Exner V, Probst A, Gruissem W, Hennig L. 2006. Functional genomic analysis of CAF-1 mutants in Arabidopsis thaliana. J Biol Chem 281: 9560–9568. 10.1074/jbc.M513426200 [DOI] [PubMed] [Google Scholar]
  47. Schübeler D. 2015. Function and information content of DNA methylation. Nature 517: 321–326. 10.1038/nature14192 [DOI] [PubMed] [Google Scholar]
  48. Sellars M, Huh JR, Day K, Issuree PD, Galan C, Gobeil S, Absher D, Green MR, Littman DR. 2015. Regulation of DNA methylation dictates Cd4 expression during the development of helper and cytotoxic T cell lineages. Nat Immunol 16: 746–754. 10.1038/ni.3198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, Taniuchi I. 2008. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319: 822–825. 10.1126/science.1151844 [DOI] [PubMed] [Google Scholar]
  50. Shan Q, Zeng Z, Xing S, Li F, Hartwig SM, Gullicksrud JA, Kurup SP, Van Braeckel-Budimir N, Su Y, Martin MD, et al. 2017. The transcription factor Runx3 guards cytotoxic CD8+ effector T cells against deviation towards follicular helper T cell lineage. Nat Immunol 18: 931–939. 10.1038/ni.3773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Smith ZD, Meissner A. 2013. DNA methylation: roles in mammalian development. Nat Rev Genet 14: 204–220. 10.1038/nrg3354 [DOI] [PubMed] [Google Scholar]
  52. Smith S, Stillman B. 1989. Purification and characterization of CAF-I, a human cell factor required for chromatin assembly during DNA replication in vitro. Cell 58: 15–25. 10.1016/0092-8674(89)90398-X [DOI] [PubMed] [Google Scholar]
  53. Taniuchi I. 2016. Views on helper/cytotoxic lineage choice from a bottom-up approach. Immunol Rev 271: 98–113. 10.1111/imr.12401 [DOI] [PubMed] [Google Scholar]
  54. Taniuchi I, Sunshine MJ, Festenstein R, Littman DR. 2002. Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. Mol Cell 10: 1083–1096. 10.1016/S1097-2765(02)00735-9 [DOI] [PubMed] [Google Scholar]
  55. Tchenio T, Casella JF, Heidmann T. 2001. A truncated form of the human CAF-1 p150 subunit impairs the maintenance of transcriptional gene silencing in mammalian cells. Mol Cell Biol 21: 1953–1961. 10.1128/MCB.21.6.1953-1961.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Tucker KL, Beard C, Dausmann J, Jackson-Grusby L, Laird PW, Lei H, Li E, Jaenisch R. 1996. Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Dev 10: 1008–1020. 10.1101/gad.10.8.1008 [DOI] [PubMed] [Google Scholar]
  57. Verbaro DJ, Sakurai N, Kim B, Shinkai Y, Egawa T. 2018. Cutting edge: the histone methyltransferase G9a is required for silencing of helper T lineage-associated genes in proliferating CD8T cells. J Immunol 200: 3891–3896. 10.4049/jimmunol.1701700 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Weber CM, Henikoff S. 2014. Histone variants: dynamic punctuation in transcription. Genes Dev 28: 672–682. 10.1101/gad.238873.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Yadav T, Quivy JP, Almouzni G. 2018. Chromatin plasticity: a versatile landscape that underlies cell fate and identity. Science 361: 1332–1336. 10.1126/science.aat8950 [DOI] [PubMed] [Google Scholar]
  60. Yang BX, El Farran CA, Guo HC, Yu T, Fang HT, Wang HF, Schlesinger S, Seah YF, Goh GY, Neo SP, et al. 2015. Systematic identification of factors for provirus silencing in embryonic stem cells. Cell 163: 230–245. 10.1016/j.cell.2015.08.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Ye X, Franco AA, Santos H, Nelson DM, Kaufman PD, Adams PD. 2003. Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest. Mol Cell 11: 341–351. 10.1016/S1097-2765(03)00037-6 [DOI] [PubMed] [Google Scholar]
  62. Yu M, Wan M, Zhang J, Wu J, Khatri R, Chi T. 2008. Nucleoprotein structure of the CD4 locus: implications for the mechanisms underlying CD4 regulation during T cell development. Proc Natl Acad Sci 105: 3873–3878. 10.1073/pnas.0800810105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Zhang K, Gao Y, Li J, Burgess R, Han J, Liang H, Zhang Z, Liu Y. 2016. A DNA binding winged helix domain in CAF-1 functions with PCNA to stabilize CAF-1 at replication forks. Nucleic Acids Res 44: 5083–5094. 10.1093/nar/gkw106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Zhang ZM, Lu R, Wang P, Yu Y, Chen D, Gao L, Liu S, Ji D, Rothbart SB, Wang Y, et al. 2018. Structural basis for DNMT3A-mediated de novo DNA methylation. Nature 554: 387–391. 10.1038/nature25477 [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Zou YR, Sunshine MJ, Taniuchi I, Hatam F, Killeen N, Littman DR. 2001. Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat Genet 29: 332–336. 10.1038/ng750 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material

Articles from Genes & Development are provided here courtesy of Cold Spring Harbor Laboratory Press

RESOURCES